Walk Vascular and Veryan Medical have announced that Veryan Medical will support commercialisation of the Jeti peripheral thrombectomy system (Walk Vascular) in Germany.
Walk Vascular’s Jeti thrombectomy system employs an internal jet, located safely just inside its catheter mouth, capable of engaging large thrombus volumes through a miniature lumen, rapidly clearing peripheral vessels that can often prove challenging for standard aspiration devices.
“By working with Veryan Medical we can hit the ground running” comments David Look, president and CEO of Walk Vascular. “Veryan provides an invaluable catalyst to our commercial efforts, providing access to key opinion leaders in Germany through an experienced sales team with clinical expertise.”
“We are pleased to be working with Walk Vascular and the Jeti technology, a proven solution that safely and effectively restores blood flow in peripheral thrombectomy procedures,” says Nick Yeo, Veryan Medical’s CEO. “We are proud to support innovators like Walk Vascular to provide insights, marketing strategy, and a top-tier salesforce to ensure commercial success and clinical adoption. JETi and Veryan’s novel BioMimics 3D stent are an exciting combination both for our sales team and our customers.”